)
)
Michelle Chen
Chief Business Officer,
Insilico Medicine
Michelle Chen is the Chief Business Officer of Insilico Medicine, a global leader in generative AI-driven drug discovery & development. She is responsible for the company’s business and corporate development, portfolio strategies, marketing, and US operations.
As a biotech executive, Michelle brings in 20+ years of experience in the biopharma and life sciences industries, having worked at multi-national companies such as Roche, Merck, BioMarin, Agilent, as well as small biotech companies. She has a strong track record of success in company building, BD&L, M&A, R&D, marketing, and product commercialization.
Michelle has a Ph.D. in Biochemistry from the University of Washington, did her postdoctoral work at UCSF, and received Bioinformatics training at Stanford.
As a biotech executive, Michelle brings in 20+ years of experience in the biopharma and life sciences industries, having worked at multi-national companies such as Roche, Merck, BioMarin, Agilent, as well as small biotech companies. She has a strong track record of success in company building, BD&L, M&A, R&D, marketing, and product commercialization.
Michelle has a Ph.D. in Biochemistry from the University of Washington, did her postdoctoral work at UCSF, and received Bioinformatics training at Stanford.
Sessions
-
11-Dec-2024The AI Accelerator StageHow Venture Capital Partnerships Drive Healthcare AI Innovation
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
.jpg/fit-in/500x500/filters:no_upscale()){kind=logo}
)
.jpg/fit-in/500x500/filters:no_upscale())
){kind=logo}
){kind=logo}
)
)
)
)
)
)
){kind=logo}
)